Press Release – Histogen Receives Patent for Hair Growth Composition
Snippet from the press release:
Histogen, Inc., a regenerative medicine company developing innovative therapies based on the products of cells grown under simulated embryonic conditions, today announced that the United States Patent & Trademark Office has issued patent 8,535,913, entitled â€œSoluble Composition for Promoting Hair Growth Produced by Hypoxic Culture of Fibroblast Cellsâ€.
The patent, which is the fourth US patent issued to the Company, covers the liquid composition of proteins and cofactors that is secreted by multipotent stem cells through Histogen’s technology process, and the method of administering that composition to stimulate hair growth. Histogen’s Hair Stimulating Complex (HSC), covered by this new patent, is in clinical development as an injectable treatment for male pattern and female diffuse hair loss.
Read the rest — Histogen’s Composition for Hair Growth Receives US Patent
Share this entry
Leave a CommentWant to join the discussion? Feel free to contribute! Note: We do not tolerate offensive language or personal attacks to other readers. Marketing links or commercial advertisements will be deleted.